Experts will identify clinical strategies for early detection and treatment
The University of Hawaii Cancer Center and The Queen's Medical Center (QMC) will host an international symposium on Friday, December 2, 2011 from 8:15 a.m. - 4:30 p.m. at The Queen's Conference Center Auditorium to discuss new information related to the recent discovery of the BAP1 genetic mutation and its link to mesothelioma, melanoma and potentially other cancers.
The Third Annual Translational Cancer Medicine Symposium will feature more than 20 global experts in cancer genetics including keynote speaker, Carlo M. Croce, M.D., Director of the Human Cancer Genetics Program of The Ohio State University; Joseph Testa, Ph.D., Director of the Genomics Facility at Fox Chase Cancer Center; and Michele Carbone, M.D., Ph.D., Director of the University of Hawaii Cancer Center whose research team announced in August its discovery of the BAP1 gene mutation's link to mesothelioma and other cancers. "We are excited to bring these experts to Hawaii to work together to find ways to reduce the suffering and death from cancers caused by this mutation," said Carbone.
Air pollution linked to head and neck cancer risk